Article
TERT promoter mutation predicts the prognosis value of patients with HBV- related HCC who underwent hepatectomy
2022-11-07
Abstract excerpt
<h4>Background and Aims: </h4> Recurrence is the major cause of poor prognosis in hepatocellular carcinoma (HCC), especially in those infected with HBV. Telomerase reverse transcriptase (TERT) promoter is the most prevalent site in HBV-related HCC. We attempted to evaluate the prognostic value of TERT mutation status in HBV-related HCC patients. <h4>Methods: </h4> We enrolled the 66 HBV-related HCC patients who un...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1d2defa2-903e-5a32-a859-f631db1488c1
- DOI
- 10.21203/rs.3.rs-2237837/v1
